NASDAQ:PACB
Pacific Biosciences of California Stock News
$2.02
-0.170 (-7.76%)
At Close: May 17, 2024
PacBio Grants Equity Incentive Award to New Employee
04:30pm, Friday, 22'nd Mar 2024
MENLO PARK, Calif., March 22, 2024 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of t
Pacific Biosciences' Pivot: From Shareholder Dilution To Expansion And Leadership
12:42pm, Tuesday, 19'th Mar 2024
PacBio expands product adoption, introducing Revio and Onso, enhancing market and technological reach. Despite 10% growth since 2015, dilution eroded shareholder value; pivot possible with 25% growth
Top 5 Health Care Stocks Which Could Rescue Your Portfolio In March - Inspire Veterinary (NASDAQ:IVP), Fractyl Health (NASDAQ:GUTS)
08:08am, Tuesday, 19'th Mar 2024
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
PacBio's (PACB) New Panel to Aid Its Clinical Research Solution
11:21am, Wednesday, 13'th Mar 2024
PacBio (PACB) announces the PureTarget repeat expansion panel, which is the HiFi long-read sequencing that supports comprehensive analysis of 20 genes associated with neurological diseases.
PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions
09:05am, Tuesday, 12'th Mar 2024
HiFi Long-Read Sequencing Panel Supports Comprehensive Analysis of 20 Genes Associated With Neurological Disease MENLO PARK, Calif. , March 12, 2024 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading d
PacBio (PACB) Q4 Earnings Beat, Adjusted Gross Margin Down
11:51am, Friday, 16'th Feb 2024
PacBio (PACB) witnesses strong revenue growth in the fourth quarter, partly aided by customers' continued product transition to the Revio system.
Pacific Biosciences (PACB) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
07:31pm, Thursday, 15'th Feb 2024
While the top- and bottom-line numbers for Pacific Biosciences (PACB) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key me
Pacific Biosciences of California, Inc. (PACB) Q4 2023 Earnings Call Transcript
06:39pm, Thursday, 15'th Feb 2024
Pacific Biosciences of California, Inc. (PACB) Q4 2023 Earnings Call Transcript
Pacific Biosciences of California (PACB) Reports Q4 Loss, Tops Revenue Estimates
06:31pm, Thursday, 15'th Feb 2024
Pacific Biosciences of California (PACB) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.35 per share a year ago.
7 Stocks Cathie Wood Is Still Loading Up On in Q1
01:59pm, Tuesday, 13'th Feb 2024
You can't say Cathie Wood is afraid to make big bets. The investing guru is more than willing to lay it all on the line for stocks she believes in.
PacBio's (PACB) New Kits to Boost Its Revio Sequencing System
10:47am, Tuesday, 06'th Feb 2024
PacBio's (PACB) new library preparation kits are likely to boost Revio's long-read sequencing systems by reducing cost and workflow time.
PacBio's (PACB) New PanDNA Kit Ready to Boost DNA Extraction
01:32pm, Tuesday, 16'th Jan 2024
PacBio's (PACB) new offering, PanDNA kit, is likely to help researchers effectively extract DNA optimized for HiFi sequencing. This versatile Nanobind kit is expected to be available in February 2024.
PacBio (PACB) Preliminary Q4 Revenues Boosted by Revio Sales
12:02pm, Tuesday, 09'th Jan 2024
PacBio's (PACB) revenue growth in the fourth quarter is likely to have been boosted by continued strength in its sequencing systems.
PacBio to Present at 42nd Annual J.P. Morgan Healthcare Conference
04:05pm, Wednesday, 27'th Dec 2023
MENLO PARK, Calif. , Dec. 27, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be presenting
Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now
09:46am, Tuesday, 26'th Dec 2023
PacBio's (PACB) product development activities raise optimism about the stock.